MedPath

Effects of Short-term Interventions for a Healthy Lifestyle on the Human Lipidome in Subjects With Metabolic Syndrome

Not Applicable
Conditions
Obesity
Metabolic Syndrome
NAFLD
Hypertension
Interventions
Behavioral: Lifestyle intervention (physical activity)
Dietary Supplement: Lifestyle intervention (PUFA/isomaltulose-enriched muffin)
Registration Number
NCT03047655
Lead Sponsor
German Institute of Human Nutrition
Brief Summary

A growing number of cross-sectional studies is investigated the role of the human lipidome as a new biomarker for metabolic diseases. However, data on this issue is still sparse and especially interventional data is not available up to now.

"GesundLeben" will provide data on 100 human subjects with metabolic syndrome, undergoing distinct types of lifestyle intervention for 6 weeks. Standardized metabolic assessment will be covered with routine laboratory parameters and oral glucose tolerance test as well as non-radiologic anthropometric measurements.

Detailed Description

A growing number of cross-sectional studies is investigated the role of the human lipidome as a new biomarker for metabolic diseases. However, data on this issue is still sparse and especially interventional data is not available up to now. We intend to clarify, if the human lipidome is correlating with metabolic state and if changes in this state reflect on the lipidome. Using high-throughput shot-gun technique, we will be able to measure several hundreds of lipid species in one blood sample.

The "GesundLeben" trial will provide data on 100 human subjects with metabolic syndrome, undergoing distinct types of lifestyle intervention for 6 weeks. The cohort will be designed to include participants from both sexes, but be restricted on subjects without impaired glucose tolerance.

Standardized metabolic assessment will be covered with routine laboratory parameters (e.g. transaminases, HbA1c) and oral glucose tolerance test as well as non-radiologic anthropometric measurements (BMI, WHR, BIA).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • hypertension
  • NAFLD
  • obesity
  • hyperuricemia
  • dyslipoproteinemia
Exclusion Criteria
  • prediabetes / overt diabetes mellitus
  • present cancer
  • systemic infection
  • chronic inflammatory disease
  • recent stroke / myocardial infarction (6 months)
  • pregnancy
  • addiction / severe psychiatric diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physical activity onlyLifestyle intervention (physical activity)pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal
Physical activity + Dietary treatmentLifestyle intervention (physical activity)pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal additionally, subjects will be provided with one healthy muffin per day (450 kcal; low GI, high load of PUFA and isomaltulose) over 6 weeks
Physical activity + Dietary treatmentLifestyle intervention (PUFA/isomaltulose-enriched muffin)pedometers have to be used throughout all days; daily amount of steps is reported via App or website; 10000 steps are defined as daily goal additionally, subjects will be provided with one healthy muffin per day (450 kcal; low GI, high load of PUFA and isomaltulose) over 6 weeks
Primary Outcome Measures
NameTimeMethod
reduction of blood pressure6 weeks

systolic and diastolic blood pressure

change in lipidome pattern6 weeks

complex human lipidome (blood levels of several hundreds of lipid species) will be assessed before and after intervention

NAFLD reduction6 weeks

NAFLD, estimated by fatty liver index (FLI)

weight loss6 weeks

loss in body weight / BMI

Secondary Outcome Measures
NameTimeMethod
improvement in quality of life6 weeks

standardized questionnaires

reduction of insulin resistance6 weeks

assessed by oral glucose tolerance test, glucose and insulin levels; IS indices (Matsuda, IGI etc.)

Trial Locations

Locations (2)

German Institut for Human Nutrition; Department for Clinical Nutrition

🇩🇪

Bergholz-Rehbrücke, Brandenburg, Germany

DIfE (German Institute for Human Nutrition)

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath